Strengthening Store Development and Support for Physicians Opening Practices
First written in FY2016. 29 of 32 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-11-10.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「In the community pharmacy segment, the Company continued to focus on new store openings, opening 17 new community pharmacies, including 13 mall-format stores, during the fiscal year and acquiring 9 community pharmacies through M&A. Meanwhile, it closed 11 stores and transferred businesses. As of 31 March 2026, the store count was 472 community pharmacies, 1 care plan center and 7 drugstores.」
Opened 17 new stores, including mall-format stores, acquired 9 stores through M&A, and closed or transferred 11 stores, advancing the expansion and restructuring of the store network. - 2026-05-29AdvancedGeneral Meeting of Shareholders
「当連結会計年度中にモール型店舗13店舗を含む地域薬局17店舗を新規出店したほか、Ｍ＆Ａにより地域薬局９店舗を取得しました。一方で、11店舗の閉鎖及び事業譲渡を行い、2026年３月31日現在の店舗数は、地域薬局472店舗、ケアプランセンター１店舗、ドラッグストア７店舗となりました。」
新規出店、M&A、閉鎖及び事業譲渡を組み合わせた店舗網の再編が継続し、地域薬局は472店舗となった。 - FY2026-H1AdvancedAnnual report
「In the community pharmacy segment, the Company continued to focus on new store openings, opening 7 new community pharmacies, including 5 mall-format stores, during the six-month consolidated period and acquiring 8 community pharmacies through M&A. Meanwhile, it closed 3 stores and transferred businesses. As of 30 September 2025, the store count was 469 community pharmacies, 1 care plan center and 9 drugstores.」
Opened 7 new stores, including mall-format stores, acquired 8 stores through M&A, and closed or transferred 3 stores, bringing the number of community pharmacies to 469. - FY2025AdvancedAnnual report
「During the fiscal year, the Company opened 21 new community pharmacies, including 12 mall-format stores, and acquired 1 community pharmacy through M&A, while closing 15 stores and transferring businesses. As of 31 March 2025, the store count was 457 community pharmacies, 1 care plan center and 8 drugstores.」
Restructured the store network through a combination of new store openings, including mall-format stores, M&A, closures and business transfers, bringing the number of community pharmacies to 457. - FY2025-H1AdvancedAnnual report
「During the six-month consolidated period, the Company opened 11 new community pharmacies, including 7 mall-format stores, and acquired 1 community pharmacy through M&A, while closing 10 stores and transferring businesses. As of 30 September 2024, the store count was 452 community pharmacies, 1 care plan center and 9 cosmetics and drugstores.」
Implemented new store openings, including mall-format stores, M&A, closures and business transfers, advancing the restructuring of the store network. The number of community pharmacies reached 452. - FY2024-Q2AdvancedAnnual report
「During the cumulative consolidated period of the second quarter, the Company opened 8 new community pharmacies, including 4 mall-format stores. As of 30 September 2023, the store count was 434 community pharmacies, 1 care plan center and 10 cosmetics and drugstores.」
Opened 8 new community pharmacies, including 4 mall-format stores, bringing the number of community pharmacies to 434. - FY2024-Q1AdvancedAnnual report
「During the cumulative consolidated period of the first quarter, the Company opened 2 new community pharmacies, including 1 mall-format store. As of 30 June 2023, the store count was 430 community pharmacies, 1 care plan center and 9 cosmetics and drugstores.」
Opened 2 new community pharmacies, including 1 mall-format store, bringing the number of community pharmacies to 430. - FY2023-Q3AdvancedAnnual report
「During the cumulative consolidated period of the third quarter, the Company opened 6 new community pharmacies, including 5 mall-format stores, and acquired 1 company with 1 store through a share acquisition. As of 31 December 2022, the store count was 429 community pharmacies, 1 care plan center and 9 cosmetics and drugstores.」
Opened 6 new community pharmacies, including 5 mall-format stores, and acquired 1 company with 1 store through a share acquisition, bringing the number of community pharmacies to 429. - FY2023-Q2AdvancedAnnual report
「During the cumulative consolidated period of the second quarter, the Company opened 4 new community pharmacies, including 3 mall-format stores. As of 30 September 2022, the store count was 427 community pharmacies, 1 care plan center and 9 cosmetics and drugstores.」
Opened 4 new community pharmacies, including 3 mall-format stores, bringing the number of community pharmacies from 425 at the end of March 2022 to 427. - FY2023-Q1AdvancedAnnual report
「During the cumulative consolidated period of the first quarter, the Company opened 3 new community pharmacies, including 2 mall-format stores. As of 30 June 2022, the store count was 426 community pharmacies, 1 care plan center and 8 cosmetics and drugstores.」
Opened 3 new community pharmacies, including 2 mall-format stores, bringing the number of community pharmacies from 425 at the end of the previous fiscal year to 426. - FY2022AdvancedAnnual report
「As of 31 March 2022, the store count was 425 community pharmacies, 1 care plan center and 8 cosmetics and drugstores.」
The number of community pharmacies increased from 416 at the end of the previous fiscal year to 425. - FY2022-Q3AdvancedAnnual report
「In December, the Company opened 2 station-based pharmacies in Fukuoka Prefecture as a new store format. The pharmacies accept prescriptions from a wide range of medical institutions by using the prescription transmission function of the official LINE account "つながる薬局." As of 31 December 2021, the store count was 424 dispensing pharmacies, 1 care plan center and 8 cosmetics and drugstores.」
Opened 2 station-based pharmacies in Fukuoka Prefecture using LINE's prescription transmission function, bringing the number of dispensing pharmacy stores to 424. - FY2022-Q1AdvancedAnnual report
「The consolidated subsidiary なの花北海道 acquired all shares of 有限会社クリニクス on 1 April 2021.」
なの花北海道 acquired all shares of 有限会社クリニクス, continuing store development and business expansion. - FY2021AdvancedAnnual report
「The consolidated subsidiary なの花東日本 acquired all shares of メトロファーマシー on 8 February 2021.」
なの花東日本 acquired all shares of メトロファーマシー, continuing to expand its pharmacy store network. - FY2020-Q3AdvancedAnnual report
「The consolidated subsidiary なの花東日本 acquired all shares of セントラルファーマシー on 27 November 2019.」
なの花東日本 acquired all shares of セントラルファーマシー and continued store development and M&A in the dispensing pharmacy business. - FY2020-Q1AdvancedAnnual report
「In the dispensing pharmacy segment, performance was supported by stores acquired through M&A, in addition to steady sales at existing stores. As of 30 June 2019, the store count was 421 dispensing pharmacies, 1 care plan center and 8 drugstores.」
Stores acquired through M&A contributed to performance, and the number of dispensing pharmacy stores increased from 420 at the end of March 2019 to 421. - FY2019AdvancedAnnual report
「The Company opened 5 new dispensing pharmacies and acquired 2 companies with 25 stores through share acquisitions and 5 stores through business acquisitions, while closing 11 stores, including 3 drugstores, and transferring 6 businesses.」
Continued new store openings, share acquisitions and business acquisitions, while also carrying out closures and business transfers to restructure the store network. - FY2019-Q3AdvancedAnnual report
「During the cumulative consolidated period of the third quarter, the Company opened 5 new dispensing pharmacies and acquired 1 company with 2 stores through a share acquisition and 5 stores through business acquisitions, while closing 5 dispensing pharmacies and 1 drugstore. As of 31 December 2018, the store count was 406 dispensing pharmacies, 1 care plan center and 7 drugstores.」
Continued new store openings, share acquisitions and business acquisitions, restructuring the store network including closures. The number of dispensing pharmacy stores increased from 405 at the end of September 2018 to 406. - FY2019-Q2AdvancedAnnual report
「During the cumulative consolidated period of the second quarter, the Company opened 2 new dispensing pharmacies and acquired 5 stores through a business acquisition, while closing 1 dispensing pharmacy and 1 drugstore. As of 30 September 2018, the store count was 405 dispensing pharmacies, 1 care plan center and 7 drugstores.」
Opened 2 new dispensing pharmacies and acquired 5 stores through a business acquisition, continuing store development. - FY2019-Q1AdvancedAnnual report
「During the cumulative consolidated period of the first quarter, the Company opened 2 new dispensing pharmacies and acquired 5 stores through a business acquisition, while closing 1 drugstore. As of 30 June 2018, the store count was 406 dispensing pharmacies, 1 care plan center and 7 drugstores.」
Opened 2 new dispensing pharmacies and acquired 5 stores through a business acquisition, while closing 1 drugstore. The number of dispensing pharmacy stores at period-end was 406. - FY2018AdvancedAnnual report
「In the dispensing pharmacy business, the Company will work to respond to revisions to dispensing fees, acquire prescriptions by fulfilling its role as a family pharmacy, improve the quality of medical care, and strengthen its home-care and health-support functions. It is targeting an increase of 20 stores through new store development and M&A.」
A specific target was set for the following fiscal year to increase the store count by 20 through new store development and M&A. For the full year, the Company opened 8 new stores and acquired 7 companies with 19 stores, while also advancing its dominant presence in the Tohoku region through the acquisition of Apotek. - FY2018-Q3AdvancedAnnual report
「During the cumulative consolidated period of the third quarter, the Company opened 8 new dispensing pharmacies and acquired 3 companies (5 stores) through share acquisitions, while closing 3 stores and transferring 2 businesses. It also merged 3 group companies, thereby strengthening its earnings base.」
Implemented new store openings, share acquisitions, store closures, business transfers and the merger of 3 group companies, continuing the development of stores and restructuring of the business base. - FY2018-Q2AdvancedAnnual report
「During the cumulative consolidated period of the second quarter, the Company opened 6 new dispensing pharmacies and acquired 3 companies (5 stores) through share acquisitions, while closing 3 stores and transferring 1 business. It also merged 2 group companies, thereby strengthening its earnings base.」
Implemented new store openings, share acquisitions, business transfers and the merger of 2 group companies, advancing the development of stores and restructuring of the business base. - FY2017AdvancedAnnual report
「The Company opened 8 new dispensing pharmacies, acquired 8 companies (18 stores) through share acquisitions and 2 stores through business acquisitions, while closing 4 stores and transferring businesses.」
During the fiscal year, continued new store openings, share acquisitions and business acquisitions, while also restructuring the store network through closures and business transfers. - FY2017-Q3AdvancedAnnual report
「During the cumulative consolidated period of the third quarter, the Company opened 8 new dispensing pharmacies, acquired 7 companies (17 stores) through share acquisitions and 2 stores through business acquisitions, while closing 3 stores and transferring businesses. It also merged 5 group companies, thereby strengthening its earnings base.」
Continued new store openings, share acquisitions and business acquisitions, and also merged 5 companies. For the integrated medical and nursing care facility "Wisteria Minami 1-jo (provisional name)," a plan was presented with a planned investment of ¥5,580 million and completion scheduled for September 2018. - FY2017-Q2AdvancedAnnual report
「During the cumulative consolidated period of the second quarter, the Company opened 7 new dispensing pharmacies, acquired 5 companies (15 stores) through share acquisitions and 2 stores through business acquisitions, while closing 3 stores and transferring businesses.」
Continued new store openings, share acquisitions and business acquisitions, implementing store development that also included closures and business transfers. - FY2017-Q1AdvancedAnnual report
「During the first quarter of the fiscal year under review, the Company opened 6 dispensing pharmacies, acquired 13 pharmacies through the acquisition of 3 companies and acquired 2 pharmacies through business transfers, while closing 1 store.」
Advanced store development through new openings, share acquisitions and business acquisitions, acquiring and opening a total of 21 stores during the quarter. - FY2016First statedAnnual report
「Further strengthening store development and support for physicians opening practices」
The policy is to combine new store openings centered on medical malls with efforts to attract clinics and support physicians opening practices.